Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Barclays (BARC) by Christopher Ruane in The Motley Fool
- Buy easyJet (EZJ) by Tom Winnifrith in ShareProphets
- Buy easyJet (EZJ) by Steve Moore in ShareProphets
- Avoid Tekmar Group (TGP) by Steve Moore in ShareProphets
- Buy Tristel (TSTL) by Mark Rogers in The Motley Fool
- Sell Mind Gym (MIND) by Steve Moore in ShareProphets
- Neutral Rio Tinto (RIO) by UBS
- Buy Baltic Classifieds Group (BCG) by Berenberg
- Underperform Whitbread (WTB) by Bernstein
- Buy Rolls-Royce Holdings (RR.) by Bank of America
- Buy Melrose Industries (MRO) by Bank of America
- Buy BAE Systems (BA.) by Bank of America
- Buy Babcock International Group (BAB) by Bank of America
- Buy Sirius Real Estate Ltd. (SRE) by Deutsche Bank
- Buy Helical (HLCL) by Deutsche Bank
- Buy Balfour Beatty (BBY) by Deutsche Bank
- Buy Discoverie Group (DSCV) by Deutsche Bank
- Hold Derwent London (DLN) by Deutsche Bank
- Buy Workspace Group (WKP) by Deutsche Bank
- Buy AJ Bell (AJB) by Deutsche Bank
BioPharma Credit (BPCR) Share Price
Financial Services Sector
NOTE: This is based on 3 open tips for BioPharma Credit (BPCR)
| Latest Bid : 1.06p | Latest Ask : 1.07p |
| High Today : 1.07p | Low Today : 1.06p |
| This Years High : 1.12p | This Years Low : 1.00p |
| Volume : 23,958 | MKT Cap : £12.73M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
BioPharma Credit (BPCR) Overview
BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit's primary objective is to generate predictable income for shareholders over the long term.BioPharma Credit (BPCR) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Jefferies | Premium Only | 2024-02-07 06:19:00 07/02/2024 | – |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2024-02-02 06:00:00 02/02/2024 | – |
| Buy | Richard Evans | Premium Only | 2023-11-23 06:00:00 23/11/2023 | – |
| Buy | Jefferies | Premium Only | 2023-09-18 04:52:00 18/09/2023 | – |
| Buy | Richard Evans | Premium Only | 2022-01-21 07:50:00 21/01/2022 | – |
BioPharma Credit (BPCR) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1.06p | Latest Ask : 1.07p |
| High Today : 1.07p | Low Today : 1.06p |
| This Years High : 1.12p | This Years Low : 1.00p |
| Volume : 23,958 | MKT Cap : £12.73M |
BioPharma Credit Overview
BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit's primary objective is to generate predictable income for shareholders over the long term.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest BioPharma Credit Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Jefferies | Premium Only | 2024-02-07 06:19:00 07/02/2024 | – |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2024-02-02 06:00:00 02/02/2024 | – |
| Buy | Richard Evans | Premium Only | 2023-11-23 06:00:00 23/11/2023 | – |
| Buy | Jefferies | Premium Only | 2023-09-18 04:52:00 18/09/2023 | – |
| Buy | Richard Evans | Premium Only | 2022-01-21 07:50:00 21/01/2022 | – |